Bridgefront Capital’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Bridgefront Capital's ASTH Position: Q2 2026 in Review
Bridgefront Capital sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 13,206 shares — an estimated $324K sold.
Bridgefront Capital first reported a position in ASTH in Q3 2025 and held it in 2 quarters. The position peaked at $324K in Q1 2026. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Bridgefront Capital reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
- Bridgefront Capital sold 13,206 Astrana Health shares in Q2 2026, an estimated $324K.
- Bridgefront Capital first reported a position in Astrana Health in Q3 2025 and held it in 2 quarters.
- Bridgefront Capital's Astrana Health position peaked at $324K in Q1 2026.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.